First establish whether the exact arrangement is eligible and adequately controlled. Only then compare its operational and commercial merits. A low price must never compensate for an unresolved supply-route, licensing, provenance, quality or patient-safety issue.
This scorecard recommends two sequential decisions:
- Qualification: seven non-negotiable gates, each marked PASS, HOLD or FAIL.
- Selection: eight weighted criteria, scored from 0 to 5 and converted into a total out of 100.
The recommended award threshold is 80/100, with every gate passed and no weighted criterion below 3/5. A result of 70–79 supports further negotiation or a controlled pilot—not an automatic network-wide award.
These weights, thresholds, evidence caps and pilot rules are this desk’s proposed procurement methodology. They are not regulatory requirements, validated predictors of patient outcomes or observed industry benchmarks. No named supplier has been audited or ranked in this document. Qualified US counsel, clinical leadership and security reviewers retain their respective approval responsibilities.
Sources cited on this page
See the section’s source register for the research context.
Section sources →